Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
199,9 USD | +1,73 % | +1,67 % | -12,06 % |
13.06. | LABCORP HOLDINGS INC. : Baird bekräftigt seine neutrale Bewertung | ZM |
05.06. | LABCORP HOLDINGS INC. : HSBC bleibt neutral | ZM |
Kurzporträt
Mitarbeiterzahl: 61 975
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Diagnostics Laboratories
77,4
%
| 9 204 | 61,9 % | 9 415 | 77,4 % | +2,30 % |
Biopharma Laboratory Services
22,8
%
| 5 710 | 38,4 % | 2 774 | 22,8 % | -51,42 % |
Intercompany Eliminations and Other
-0,2
%
| -37 | -0,2 % | -28 | -0,2 % | -24,93 % |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
83,7
%
| 11 531 | 77,5 % | 10 178 | 83,7 % | -11,73 % |
Europe
9,0
%
| 1 934 | 13,0 % | 1 095 | 9,0 % | -43,40 % |
Other
4,0
%
| 1 041 | 7,0 % | 486 | 4,0 % | -53,29 % |
North America
3,3
%
| 371 | 2,5 % | 403 | 3,3 % | +8,61 % |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Adam Schechter
CEO | Chief Executive Officer | 59 | 01.04.13 |
Glenn Eisenberg
DFI | Director of Finance/CFO | 62 | 16.06.14 |
Compliance Officer | 65 | 01.02.19 | |
Mark Schroeder
COO | Chief Operating Officer | 63 | 01.05.07 |
Lance Berberian
CTO | Chief Tech/Sci/R&D Officer | 61 | 01.02.14 |
Brian Caveney
CTO | Chief Tech/Sci/R&D Officer | 50 | 25.09.17 |
Chief Tech/Sci/R&D Officer | - | - | |
Henry Dong
PRN | Corporate Officer/Principal | - | - |
George Maha
PRN | Corporate Officer/Principal | - | - |
Earle Collum
PRN | Corporate Officer/Principal | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Adam Schechter
CEO | Chief Executive Officer | 59 | 01.04.13 |
Peter Neupert
BRD | Director/Board Member | 68 | 01.01.13 |
Kerrii Anderson
BRD | Director/Board Member | 66 | 17.05.06 |
Jeffrey Davis
BRD | Director/Board Member | 60 | 01.12.19 |
Paul Rothman
BRD | Director/Board Member | 65 | 06.06.23 |
Garheng Kong
BRD | Director/Board Member | 49 | 01.12.13 |
Richelle Parham
BRD | Director/Board Member | 56 | 08.02.16 |
D. Gilliland
BRD | Director/Board Member | 69 | 01.04.14 |
Kathryn Wengel
BRD | Director/Board Member | 58 | 25.03.21 |
Director/Board Member | 57 | 12.10.22 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 84 293 628 | 84 000 632 ( 99,65 %) | 0 | 99,65 % |
Unternehmenskontakt
Laboratory Corp. of America Holdings
358 South Main Street
27215-5837, Burlington
+336 229 1127
http://www.labcorp.comKonzerngesellschaften
Name | Kategorie und Branche |
---|---|
Pharmaceuticals: Major
| |
Chiltern International Ltd.
Chiltern International Ltd. Miscellaneous Commercial ServicesCommercial Services Chiltern International, Inc. provides clinical research services. It offers clinical development, medical and scientific affairs, data and analysis, pharmacovigilance and strategic regulatory services. The firm serves biotech, pharmaceuticals, biosimilars and biologics and medical device and diagnostics industries. The company was founded in 1982 and is headquartered in Slough, the United Kingdom. |
Miscellaneous Commercial Services
|
Labcorp Early Development Laboratories Ltd.
Labcorp Early Development Laboratories Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Fortrea Holdings, Inc., Labcorp Early Development Laboratories Ltd. is a British company that provides early-stage and late-stage product development services. The company is based in Harrogate, UK. Labcorp Early Development Laboratories was founded in 1974. |
Miscellaneous Commercial Services
|
Dynacare-Gamma Laboratory Partnership
Dynacare-Gamma Laboratory Partnership Medical/Nursing ServicesHealth Services Gamma-Dynacare Medical Laboratories Inc, Providing Information, Impacting Lives, Caring for People. By living this mission, Gamma-Dynacare Medical Laboratories will achieve its vision of becoming the trusted leader in transforming laboratory information and services into solutions that improve health, wellness and the Canadian health care system. Gamma-Dynacare is one of Canada's largest and most respected providers of laboratory services and solutions, with more than 50 years of experience serving Canadians. Each day, they support tens of thousands of patients, healthcare professionals and public and private sector clients with the efficient collection and transportation of specimens, accurate testing in their state-of-the-art laboratories and prompt reporting of results. |
Medical/Nursing Services
|
Labcorp Central Laboratory Services SARL
Labcorp Central Laboratory Services SARL Miscellaneous Commercial ServicesCommercial Services Covance Central Laboratory Services SA provides diagnostic services. It also provides analytic services for the medical profession. The company was founded in 1992 and is headquartered in Meyrin-Geneva, Switzerland. |
Miscellaneous Commercial Services
|
Fortrea Development Ltd.
Fortrea Development Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Fortrea Holdings, Inc., Fortrea Development Ltd. is a British company that provides clinical development services. The company is based in Maidenhead, UK. |
Miscellaneous Commercial Services
|
Fortrea Clinical Research Unit Ltd.
Fortrea Clinical Research Unit Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Fortrea Holdings, Inc., Fortrea Clinical Research Unit Ltd. is a British clinical research company. The company is based in Leeds, UK. Founded in 1991, Fortrea Clinical Research Unit functions as a clinical research company. |
Miscellaneous Commercial Services
|
Fortrea UK Holdings Ltd.
Fortrea UK Holdings Ltd. Financial ConglomeratesFinance Part of Fortrea Holdings, Inc., Fortrea UK Holdings Ltd. is an investment holding company. Fortrea UK Holdings Ltd. is based in Harrogate, UK. Founded in 1991. |
Financial Conglomerates
|
Labcorp International Holdings BV
|
Sektor
Umsatz nach Geschäftsbereich
Umsatz je Region
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-12,06 % | 16,85 Mrd. | |
+24,67 % | 88,39 Mrd. | |
-23,73 % | 75,6 Mrd. | |
+3,24 % | 26,87 Mrd. | |
-0,02 % | 15,31 Mrd. | |
+75,93 % | 13,53 Mrd. | |
+82,63 % | 13,48 Mrd. | |
-24,56 % | 13,01 Mrd. | |
+23,23 % | 12,57 Mrd. | |
+34,75 % | 12,38 Mrd. |
- Börse
- Aktien
- A40C39 Aktie
- Unternehmen Labcorp Holdings Inc.